(S)-2-(1,3-Dioxoisoindolin-2-yl)-3-methylbutanoic acid, 98%, 100g

2-((((9h-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(5-chloro-1h-indol-3-yl)propanoic acid, 97%, 1g

2-(Dimethylamino)ethylhydrazine, 500mg

6,10-Dibenzyl-N,N'-dimethyl-N,N,N',N'-tetrakis(4-methylbenzyl)-1,4-dioxaspiro[4.5]decane-(2S,3S)-diylbis(methylammonium) Bis(tetrafluoroborate) [=(S,S)-TaDiAS-2nd]>95.0%(N)1g

4-morpholin-4-ylbutan-1-ol, 95.0%, 100mg

2,2-Bis(allyloxymethyl)-1-butanol (contains Mono- and Tri-substituted Product)>85.0%(GC)500g

1-(4-Isopropoxyphenyl)ethanone, 95.0%, 25g

3-(bromomethyl)-5-methyl-1,2,4-oxadiazole, 95.0%, 250mg

((2-Fluoro-6-(methoxymethoxy)-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalen-1-yl)ethynyl)triisopropylsilane, 97%, 1g

Benzhydrylamine, 97.0%, 100g

3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)CYCLOHEX-2-ENONE, 95.0%, 5g

Boc-L-Homophenylalanine, 97.0%, 25g

(2S,4R)-4-([1,1'-Biphenyl]-4-ylmethyl)pyrrolidine-2-carboxylic acid hydrochloride, 95.0%, 250mg